# Otolith Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/otolith-labs

- Industry: Medical Devices & Equipment
- Headquarters: Washington, US
- Website: www.otolithlabs.com
- Total disclosed funding: $20M
- Latest round: Series A (Sep 7, 2022)
- Investors on record: 1

## About

Founded in 2015 by Sam Owen (CEO), and based in Washington, DC, US, Otolith Labs, Inc. operates as a developer of prescription medical devices for the treatment of vestibular disorders such as chronic vertigo. In September 2022, Otolith Labs, Inc. raised USD 20 million in Series A funding from new investor Morningside Venture Partners from investors.

The firm offers its patented therapeutic technology, which is a medical wearable treatment for vertigo called nVSM (noninvasive Vestibular System Masking) that applies localized mechanical stimulation to the vestibular system through calibrated vibrations to help provide immediate relief to vertigo and other vestibulogenic conditions in patients suffering from vestibular disorders.

The company intends to use the September 2022 funding to further develop and support its clinical programs.

## Funding rounds

- Series A, Sep 7, 2022, $20M — Morningside

## Investors

- Morningside (https://capitalatlas.ai/funds/morningside) — Series A